EyePoint Pharmaceuticals (NASDAQ:EYPT) reported quarterly losses of $(0.52) per share which met the analyst consensus estimate. This is a 23.81 percent decrease over losses of $(0.42) per share from the same period last year. The company reported quarterly sales of $11.56 million which beat the analyst consensus estimate of $10.87 million by 6.39 percent. This is a 28.31 percent increase over sales of $9.01 million the same period last year.
Tesla Stock Is Up More Than 50% Over The Past Month: Why Jim Cramer Is Calling It ‘The Princess Bride’ Rally
Tesla Inc (NASDAQ: TSLA) shares have staged an impressive rally over the past month, setting a new record for most consecutive green days along the way.
